Meeting
2014 ASCO Annual Meeting
Combined immunophenotyping of tumor-infiltrating lymphocytes as a prognostic factor in resected patients with non-small cell lung cancer.
Authors
Ross A. Soo
National University Health System, Singapore, Singapore
Ross A. Soo , Bernadette Reyna Asuncion , Marie Loh , Zul Fazreen , Braxton Sim , Min En Nga , Yin Huei Pang , Brendan Pang , Barry Iacopetta , Richie Chuan Teck Soong
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Other
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 11125)
DOI
10.1200/jco.2014.32.15_suppl.11125
Abstract #
11125
Poster Bd #
407
Abstract Disclosures
Similar Posters
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Correlation of lung cancer mutational profile with immune profile.
First Author: Antonios Papanicolau-Sengos
Poster
2017 ASCO Annual Meeting
Immune marker profiling and PD-L1, PD-L2 expression mechanisms across non-small cell lung cancer mutations.
First Author: Maria Toki
Poster
2023 ASCO Annual Meeting
Multi-omic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes.
First Author: Brian Warnecke
Poster
2023 ASCO Annual Meeting
Role of HLA class-I antigen peptide loading complex components in immune evasion and treatment sensitivity in human lung cancer.
First Author: Adrien Costantini